Quest Diagnostics (DGX) Equity Income (2009 - 2026)

Quest Diagnostics has disclosed Equity Income across 18 years of filings, most recently posting $10.0 million for Q2 2026.

• In Q2 2026, Equity Income rose 11.11% year-over-year to $10.0 million; the TTM figure through Jun 2026 stood at $29.0 million (down 23.68% YoY), while the FY2025 annual figure was $42.0 million, up 121.05% from the prior year.
• Equity Income came in at $10.0 million for Q2 2026 at Quest Diagnostics, up from $4.0 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $31.0 million in Q1 2022 to a low of $3.0 million in Q4 2022.
• Average Equity Income over 5 years is $8.5 million, with a median of $7.0 million recorded in 2023.
• Year-over-year, Equity Income plunged 88.0% in 2022 and soared 166.67% in 2023.
• Over 5 years, Equity Income stood at $3.0 million in 2022, then soared by 166.67% to $8.0 million in 2023, then slumped by 37.5% to $5.0 million in 2024, then surged by 40.0% to $7.0 million in 2025, then surged by 42.86% to $10.0 million in 2026.
• Per Business Quant data, the three most recent Equity Income figures were $10.0 million in Q2 2026, $4.0 million in Q1 2026, and $7.0 million in Q4 2025.